NEW YORK (GenomeWeb) – Having completed the full commercial launch of its ultra-fast thermal cycler for research use earlier this year, BJS Biotechnologies is now looking to push the platform into clinical use, including near-patient testing.

To that end, the UK-based company in March said that it is spearheading a consortium that aims develop a rapid, point-of-care sepsis test on the platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.